Neuroimaging of serotonin uptake sites and antidepressant binding sites in the thalamus of humans and ‘higher’ animals

Alexander, 1986, Parallel organization of functionally segregated circuits linking basal ganglia and cortex, Annu. Rev. Neurosci., 9, 357, 10.1146/annurev.ne.09.030186.002041 Alexander, 1990, Functional architecture of basal ganglia circuits: neural substrates of parallel processing, Trends Neurol. Sci., 13, 226, 10.1016/0166-2236(90)90107-L Azmitia, 1986, The primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis, Adv. Neurol., 43, 407 Blier, 1987, Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression, J. Clin. Psychopharmacol., 7, 24S, 10.1097/00004714-198712001-00003 Bogousslaavsky, 1988, Manic delirium and frontal-like syndrome with paramedian infarction of the right thalamus, J. Neurol. Neurosurg. Psychiatry, 51, 116, 10.1136/jnnp.51.1.116 Cortés, 1988, Autoradiography of antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine, Neuroscience, 27, 473, 10.1016/0306-4522(88)90282-5 Cumming, 1993, Kinetics of the uptake of [3H]paroxetine in the rat brain, Synapse, 15, 124, 10.1002/syn.890150204 Cummings, 1984, Secondary mania with focal cerebrovascular lesions, Am. J. Psychiatry, 141, 1084, 10.1176/ajp.141.9.1084 Dechant, 1991, Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness, Drugs, 41, 225, 10.2165/00003495-199141020-00007 Drevets, 1992, A functional anatomical study of unipolar depression, J. Neurosci., 12, 3628, 10.1523/JNEUROSCI.12-09-03628.1992 Erreboe, 1995, Differences in brain 5-HT transporter dissociation rates among animal species, Pharmacol. Toxicol., 76, 376, 10.1111/j.1600-0773.1995.tb00165.x Farde, 1994, PET study of [11C]β-CIT binding to monoamine transporters in the monkey and human brain, Synapse, 16, 93, 10.1002/syn.890160203 Gensmantel, 1995, Physicochemical properties and drug design, 98 Gjedde, 1991, Modeling neuroreceptor binding of radioligands in vivo, 51 Graff-Radford, 1990, Diencephalic amnesia, Brain, 113, 1, 10.1093/brain/113.1.1 Gunasekara, 1998, Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders, Drugs, 55, 85, 10.2165/00003495-199855010-00007 Hashimotor, 1990, In vivo labeling of 5-hydroxytryptamine uptake sites in mouse brain with [3H]-6-nitroquipazine, J. Pharmacol. Exp. Ther., 225, 146 Hyttel, 1982, Citalopram — pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity, Prog. Neuro-Psychopharmacol. Biol. Psychiatr., 6, 277, 10.1016/S0278-5846(82)80179-6 Jagust, 1996, Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter, J. Nucl. Med., 37, 1207 Kaufman, 1992, Distribution of cocaine recognition sites in monkey brain: II. Ex vivo autoradiography with [3H]CFT and [125I]RTI-55, Synapse, 12, 99, 10.1002/syn.890120203 Kulisevsky, 1993, Hemiballismus and secondary mania following a right thalamic infarction, Neurology, 43, 1422, 10.1212/WNL.43.7.1422 Laruelle, 1993, SPECT imaging of dopamine and serotonin transporters with [123I]β-CIT: pharmacological characterization of brain uptake in nonhuman primates, Synapse, 13, 295, 10.1002/syn.890130402 Lavoie, 1991, Serotoninergic innervation of the thalamus in the primate: an immunohistochemical study, J. Comp. Neurol., 312, 1, 10.1002/cne.903120102 Maryanoff, 1984, Pyrrolo-isoquinoline antidepressants. Potent, enantioselective inhibition of tetrabenazine-induced ptosis and neuronal uptake of norepinephrine, dopamine, and serotonin, J. Med. Chem., 27, 943, 10.1021/jm00374a001 Meador, 1996, Dementia associated with dorsal midbrain lesion, J. Int. Neuropsychol. Soc., 2, 359, 10.1017/S1355617700001387 Meylan, 1995, Atom/fragment contribution method for estimating octanol-water partition coefficients, J. Pharm. Sci., 84, 83, 10.1002/jps.2600840120 Mukherjee, 1998, Evaluation of the binding of the radiolabeled antidepressant drug, 18F-fluoxetine in the rodent brain: an in vitro and in vivo study, Nucl. Med. Biol., 25, 605, 10.1016/S0969-8051(98)00043-2 Muth, 1986, Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative, Biochem. Pharmacol., 35, 4493, 10.1016/0006-2952(86)90769-0 Muth, 1991, Biochemical, neurophysiological, and behavioral effects of Wy-45,233 and other identified metabolites of the antidepressant venlafaxine, Drug Dev. Res., 23, 191, 10.1002/ddr.430230210 NeuroSearch AS (Moldt, P., Scheelkruger, J., Olsen, G.M., Nielsen, E.O.), 1997. 8-Azabicyclo[3.2.1]oct-2-ene derivatives, their preparation and use. WO-09713770. Owens, 1994, Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter, Clin. Chem., 40, 288, 10.1093/clinchem/40.2.288 Parent, 1981, Organization of ascending serotonin systems in the adult rat brain. A radioautographic study after intraventricular administration of [3H]5-hydroxytryptamine, Neuroscience, 6, 115, 10.1016/0306-4522(81)90050-6 Pike, 1993, Positron-emitting radioligands for studies in vivo — probes for human psychopharmacology, J. Psychopharmacol., 7, 139, 10.1177/026988119300700202 Plenge, 1990, Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine, Prog. Neuro-Psychopharmacol. Biol. Psychiatr., 14, 61, 10.1016/0278-5846(90)90064-N Rosenblith, 1961 Scheffel, 1992, [123/125I]RTI-55, an in vivo label for the serotonin transporter, Synapse, 11, 134, 10.1002/syn.890110206 Sedvall, 1986, Imaging of neurotransmitter receptors in the living human brain, Arch. Gen. Psychiatry, 43, 995, 10.1001/archpsyc.1986.01800100089012 Shiue, 1995, PET study of the distribution of [11C]fluoxetine in a monkey brain, Nucl. Med. Biol., 22, 613, 10.1016/0969-8051(94)00146-B Smith, D.F., Gee, A.D., Hansen, S.B., Moldt, P., Østergaard Nielsen, F., Scheel-Krüger, J., Gjedde, A., 1999. Cerebral distribution of a new SSRI, NS2381, studied by PET in living porcine brain. Eur. Neuropsychopharmacol 9, 351-359. Smith, D.F., Hansen, S.B., Østergaard, L., Gee, A.D., Danielsen, E., Ishizu, K., Bender, D., Poulsen, P.H., Gjedde, A., 1998. [11C]Venlafaxine and [14C]serotonin uptake in porcine brain. Nucl. Med. Biol. in press. Smith, 1991, Effects of pyrroloisoquinoline enantiomers ((+)- and (−)-McN-5652-Z) on behavioral and pharmacological serotonergic mechanisms in rats, Eur. J. Pharmacol., 196, 85, 10.1016/0014-2999(91)90412-J Smith, 1997, PET neuroimaging with [11C]venlafaxine: serotonin uptake inhibition, biodistribution and binding in living pig brain, Eur. Neuropsychopharmacol., 7, 195, 10.1016/S0924-977X(97)00403-3 Smith, 1998, Quantitative PET analysis of regional cerebral blood flow and glucose and oxygen metabolism in response to fenfluramine in living porcine brain, J. Neurosci. Methods, 86, 17, 10.1016/S0165-0270(98)00141-1 Stokes, 1997, Fluoxetine tenth anniversary update: the progress continues, Clin. Ther., 19, 1135, 10.1016/S0149-2918(97)80066-5 Szabo, 1995, Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652, Synapse, 20, 37, 10.1002/syn.890200107 Szabo, 1995, Positron emission tomography of 5-HT transporter sites in the baboon brain with [11C]McN5652, J. Cereb. Blood Flow Metab., 15, 798, 10.1038/jcbfm.1995.100 Tauscher, 1999, In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment, Eur. Neuropsychopharmacol., 9, 177, 10.1016/S0924-977X(98)00013-3 van Harten, 1993, Clinical pharmacokinetics of selective serotonin reuptake inhibitors, Clin. Pharmacokinet., 24, 203, 10.2165/00003088-199324030-00003 Verhagen, 1996, Whipple’s disease and the central nervous system. A case report and a review of the literature, Clin. Neurol. Neurosurg., 98, 299, 10.1016/0303-8467(96)00035-2 Vuilleumier, 1998, Persistent recurrence of hypomania and prosopoaffective agnosia in a patient with right thalamic infarct, Neuropsychiatr. Neuropsychol. Behav. Neurol., 11, 40 Young, 1994, Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder, Biol. Psychiatry, 35, 121, 10.1016/0006-3223(94)91201-7 Zea-Ponce, 1997, Radiosynthesis and PET imaging of [N-methyl-11C]LY257327 as a tracer for 5-HT transporters, Nucl. Med. Biol., 24, 251, 10.1016/S0969-8051(97)00062-0